Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor β2 chain expression in patients with allergic asthma

Cellular Immunology

Volumn 228, Issue 1, 2004, Pages 20-26

  Tazaki, Toshiyuki ^a   Minoguchi, Kenji ^a   Yokoe, Takuya ^a   Oda, Naruhito ^a   Hashimoto, Tadanori ^a   Tanaka, Akihiko ^a   Okada, Shinji ^a   Yamamoto, Yoshitaka ^a   Watanabe, Yoshio ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Asthma; Immunotherapy; Interferon ; Interleukin 12; Interleukin 12 receptor; Interleukin 4; T cell

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; RECOMBINANT INTERLEUKIN 12;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ARTICLE; BETA CHAIN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVOCATION TEST; TH1 CELL; TH2 CELL;

ADULT; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12;

DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE;

EID: 2942557008     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.03.008     Document Type: Article

References (36)

1. Bousquet J., Becker W.M., Hejjaoui A., Chanal I., Lebel B., Dhivert H., Michel F.B. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J. Allergy Clin. Immunol. 88:1991;43-53
2. Bousquet J., Demoly P., Michel F.B. Specific immunotherapy in rhinitis and asthma. Ann. Allergy Asthma Immunol. 87(1 Suppl. 1):2001;38-42
3. Moller C., Dreborg S., Ferdousi H.A., Halken S., Host A., Jacobsen L., Koivikko A., Koller D.Y., Niggemann B., Norberg L.A., Urbanek R., Valovirta E., Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J. Allergy Clin. Immunol. 109:2002;251-256
4. Abramson M., Puy R., Weiner J. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized clinical trials. Am. J. Respir. Crit. Care Med. 151:1995;969-974
5. Oda N., Yamashita N., Minoguchi K., Takeno M., Kaneko S., Sakane T., Adachi M. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy. Cell. Immunol. 190:1998;43-50
6. Kohno Y., Minoguchi K., Oda N., Yokoe T., Yamashita N., Sakane T., Adachi M. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J. Allergy Clin. Immunol. 102:1998;927-934
7. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory function in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027
8. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824
9. van der Pouw Kraan T.C., Boeije L.C., de Groot E.R., Stapel S.O., Snijders A., Kapsenberg M.L., van der Zee J.S., Aarden L.A. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J. Immunol. 158:1997;5560-5565
10. Naseer T., Minshall E.M., Leung D.Y., Laberge S., Ernst P., Martin R.J., Hamid Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 155:1997;845-851
11. Desai B.B., Quinn P.M., Wolitzky A.G., Mongini P.K., Chizzonite R., Gately M.K. IL-12 receptor. II Distribution and regulation of receptor expression. J. Immunol. 148:1992;125-132
12. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., Presky D.H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:1998;495-521
13. Coccia E.M., Passini N., Battistini A., Pini C., Sinigaglia F., Rogge L. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J. Biol. Chem. 274:1999;6698-6703
14. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825-833
15. Rogge L., Papi A., Presky D.H., Biffi M., Minetti L.J., Miotto D., Agostini C., Semenzato G., Fabbri L.M., Sinigaglia F. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J. Immunol. 162:1999;3926-3932
16. Varga E.M., Wachhholz P., Nouri-Arai K.T., Verhoef A., Corrigan C.J., Till S.J., Durham S.R. T cells from human allergen-induced late asthmatic responses express IL-12 receptor β2 subunit mRNA and respond to IL-12 in vitro. Am. J. Respir. Crit. Care Med. 165:2000;2877-2885
17. Yokoe T., Suzuki N., Minoguchi K., Adachi M., Sakane T. Analysis of IL-12 receptor beta 2 chain expression of circulating T lymphocytes in patients with atopic asthma. Cell. Immunol. 208:2001;34-42
18. Barnes P.J. Is immunotherapy for asthma worthwhile? N. Engl. J. Med. 334:1996;531-532
19. + T cells from allergic individuals. J. Exp. Med. 178:1993;2123-2130
20. O'Brien R.M., Byron K.A., Varigos G.A., Thomas W.R. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes. Clin. Exp. Allergy. 27:1997;46-51
21. Jutel M., Pichler W.J., Skrbic D., Urwyler A., Dahinden C., Muller U.R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:1995;4187-4194
22. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1995;1527-1536
23. Hofstra C.L., Van Ark I., Hofman G., Kool M., Nijkamp F.P., Van Oosterhout A.J. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 161:1998;5054-5060
24. Kips J.C., Brusselle G.J., Joos G.F., Peleman R.A., Tavernier J.H., Devos R.R., Pauwels R.A. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153:1996;535-539
25. Kumar M., Behera A.K., Hu J., Lockey R.F., Mohapatra S.S. IFN-gamma and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy. J. Allergy Clin. Immunol. 108:2001;402-408
26. Hogan S.P., Foster P.S., Tan X., Ramsay A.J. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 28:1998;413-423
27. Hamid Q.A., Schotman E., Jacobson M.R., Walker S.M., Durham S.R. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol. 99:1997;254-260
28. Trichieri G. Immunobiology of interleukin 12. Immunol. Res. 17:1998;269-278
29. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:2000;715-725
30. Taha R.A., Minshall E.M., Olivenstein R., Ihaku D., Wallaert B., Tsicopoulos A., Tonnel A.B., Damia R., Menzies D., Hamid Q.A. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am. J. Respir. Crit. Care Med. 160:1999;1119-1123
31. Janefjord C.K., Jenmalm M.C. PHA-induced IL-12R beta(2) mRNA expression in atopic and non-atopic children. Clin. Exp. Allergy. 31:2001;1493-1500
32. Lack G., Renz H., Saloga J., Bradley K.L., Loader J., Leung D.Y., Larsen G., Gelfand E.W. Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J. Immunol. 152:1994;2546-2554
33. Lack G., Bradley K.L., Hamelmann E., Renz H., Loader J., Leung D.Y., Larsen G., Gelfand E.W. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol. 157:1996;1432-1439
34. Boguniewicz M., Schneider L.C., Milgrom H., Newell D., Kelly N., Tam P., Izu A.E., Jaffe H.S., Bucalo L.R., Leung D.Y. Treatment of steroid-dependent asthma with recombinant interferon-gamma. Clin. Exp. Allergy. 23:1993;785-790
35. Boguniewicz M., Martin R.J., Martin D., Gibson U., Celniker A., Williams M., Leung D.Y. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J. Allergy Clin. Immunol. 95:1995;133-135
36. Hansen G., Berry G., DeKruyff R.H., Umetsu D.T. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:1999;175-183